Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RPC Diagnostic Systems is a Russian in vitro diagnostics manufacturer focused on immunodiagnostic assays, recombinant antigens, conjugates, and quality-control products for laboratory testing. The company develops and commercializes ELISA-based test kits for infectious diseases, hormone pathologies, tumor markers, and autoimmune disorders, and also provides bacteriology products for rapid microbial identification. In addition to finished diagnostic kits, it offers custom research and manufacturing services including cloning strategy design, protein expression, purification, conjugation, and assay development. The business appears to be commercially established, with broad distribution across Russia and exports to more than 50 countries, including supply under WHO and UNICEF-related programs. WHO-prequalified HIV assays indicate international regulatory traction in select IVD products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RPC Diagnostics System.